The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.

DUBLIN, CA, UNITED STATES, March 31, 2026 /EINPresswire.com/ -- Through transformative approaches to drug development, ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter: Abivax: ...

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...

HSSA Funding to Support Commercialization of Biological Testing Platform and High-Paying Bioscience Jobs in Spokane ...

Gross profit margin recorded 37.9%, a YOY increase of 3.3 pp Net profit recorded RMB269.3 million, a YOY increase 21.3% Adjusted non-IFRS net profit recorded RMB335.3 million, a YOY increase of nearly ...

April 1 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to corner a share in a sector dominated ...

EMA states that reduction in animal testing will be gradual. The first qualification opinion for a NAM used in toxicity ...